New York State Common Retirement Fund
ONC

New York State Common Retirement Fund’s BeOne Medicines Ltd ONC Stock Holding History

New York State Common Retirement Fund’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Sell
9,798
-688
-7% -$203K ﹤0.01% 1323
2026
Q1 		$3.11M Sell
10,486
-1,168
-10% -$378K ﹤0.01% 1200
2025
Q4 		$3.54M Sell
11,654
-4,241
-27% -$1.39M ﹤0.01% 1168
2025
Q3 		$5.42M Buy
15,895
+746
+5% +$227K 0.01% 1030
2025
Q2 		$3.67M Hold
15,149
– – ﹤0.01% 1193
2025
Q1 		$4.12M Buy
15,149
+2,976
+24% +$696K 0.01% 1127
2024
Q4 		$2.25M Buy
12,173
+3,604
+42% +$736K ﹤0.01% 1376
2024
Q3 		$1.92M Hold
8,569
– – ﹤0.01% 1417
2024
Q2 		$1.22M Buy
8,569
+2,648
+45% +$408K ﹤0.01% 1671
2024
Q1 		$926K Buy
+5,921
New +$953K ﹤0.01% 1805
2022
Q4 		– Sell
-275
Closed -$37K – 3262
2022
Q3 		$37K Hold
275
– – ﹤0.01% 3176
2022
Q2 		$45K Sell
275
-65,860
-100% -$10.3M ﹤0.01% 3223
2022
Q1 		$12.5M Sell
66,135
-37,475
-36% -$7.97M 0.01% 863
2021
Q4 		$28.1M Sell
103,610
-11,826
-10% -$3.99M 0.03% 509
2021
Q3 		$41.9M Hold
115,436
– – 0.04% 372
2021
Q2 		$39.6M Buy
115,436
+275
+0.2% +$91.1K 0.04% 393
2021
Q1 		$40.1M Buy
115,161
+77,686
+207% +$25.7M 0.04% 379
2020
Q4 		$9.68M Sell
37,475
-50,943
-58% -$14M 0.01% 963
2020
Q3 		$25.3M Hold
88,418
– – 0.03% 505
2020
Q2 		$16.7M Buy
88,418
+12,485
+16% +$2.03M 0.02% 658
2020
Q1 		$9.35M Buy
75,933
+8,958
+13% +$1.4M 0.01% 810
2019
Q4 		$11.1M Sell
66,975
-3,200
-5% -$532K 0.01% 918
2019
Q3 		$8.59M Sell
70,175
-14,024
-17% -$1.86M 0.01% 1007
2019
Q2 		$10.4M Buy
84,199
+186
+0.2% +$23.6K 0.01% 955
2019
Q1 		$11.1M Buy
84,013
+32,700
+64% +$4.41M 0.01% 915
2018
Q4 		$7.2M Buy
+51,313
New +$6.8M 0.01% 1031

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

New York State Common Retirement Fund's ONC Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its BeOne Medicines Ltd (ONC) stake by 6.6% in Q2 2026, selling an estimated $203K and leaving 9,798 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1323.

New York State Common Retirement Fund first reported a position in ONC in Q4 2018 and has held it in 26 quarters since. The position peaked at $41.9M in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • New York State Common Retirement Fund held 9,798 shares of BeOne Medicines Ltd worth $2.79M as of Q2 2026.
  • New York State Common Retirement Fund sold 688 BeOne Medicines Ltd shares in Q2 2026, an estimated $203K.
  • BeOne Medicines Ltd made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1323 holding.
  • New York State Common Retirement Fund first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 26 quarters since.
  • New York State Common Retirement Fund's BeOne Medicines Ltd position peaked at $41.9M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.